Hostname: page-component-7479d7b7d-767nl Total loading time: 0 Render date: 2024-07-10T22:14:06.930Z Has data issue: false hasContentIssue false

Toxic role in schizophrenia: A review by a clinical case

Published online by Cambridge University Press:  23 March 2020

A. Peña Serrano
Affiliation:
Consorcio Hospital General Universitario, Conselleria de Sanitat, Valencia, Spain
J.M. Hernández Sánchez
Affiliation:
Consorcio Hospital General Universitario, Conselleria de Sanitat, Valencia, Spain
M. Canccino Botello
Affiliation:
Consorcio Hospital General Universitario, Conselleria de Sanitat, Valencia, Spain
F. Molina López
Affiliation:
Consorcio Hospital General Universitario, Conselleria de Sanitat, Valencia, Spain
M. Machado Vera
Affiliation:
Consorcio Hospital General Universitario, Conselleria de Sanitat, Valencia, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Often find it difficult diagnostic approach to patients with symptoms that could correspond to several clinical entities. This requires making a correct differential diagnosis to enable a better understanding and addressing the disease in an individualized way.

Objective

Describe pathogenetic factors of paranoid schizophrenia highlighting their relationship with drug consumption.

Methods

Review of the clinical history of a patient admitted to acute ward of the Hospital General Universitario of Valencia.

Results

A case of a 30-year-old man, whose income is motivated by persistent and structured autolytic ideation occurs. It presents positive symptoms for several years and amotivational syndrome ago. It has a history of cannabis, cocaine and alcohol since he was thirteen and remains abstinent for more than six months ago. Differential diagnosis arises between amotivational toxic syndrome, reactive depressive symptoms to the disease and negative symptoms for chronic psychotic process. Finally diagnosed with paranoid schizophrenia and is included in the program of first psychotic episodes.

Today the productive symptoms disappeared and remain negative though with less intensity achieving an improvement in overall activity.

Conclusions

Consumption of toxic influences the development of a chronic psychotic process that may appear years later, becoming a etiological and maintainer factor, not only if its consumption continue, but other effects that occur long term amotivational syndrome and worsening prognosis.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV09
Copyright
Copyright © European Psychiatric Association 2016

References

Further readings

Luca, , et al. . Negative dimension in psychiatry. Amotivational syndrome as a paradigm of negative symptoms in substance abuse.Google Scholar
Simon, Zhornitsky, et al. Research article psychopathology in patients with substance use disorder and substance-induced without psychosis. J Addict 2015.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.